ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation

Susanne A. Schneider, Coro Paisan-Ruiz, Niall P. Quinn, Andrew J. Lees, Henry Houlden, John Hardy, Kailash P. Bhatia

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Abstract

Kufor Rakeb disease (KRD, PARK9) is an autosomal recessive extrapyramidal-pyramidal syndrome with generalized brain atrophy due to ATP13A2 gene mutations. We report clinical details and investigational results focusing on radiological findings of a genetically-proven KRD case. Clinically, there was early onset levodopa-responsive dystonia-parkinsonism with pyramidal signs and eye movement abnormalities. Brain MRI revealed generalized atrophy and putaminal and caudate iron accumulation bilaterally. Our findings add KRD to the group of syndromes of neurodegeneration with brain iron accumulation (NBIA). KRD should be considered in patients with dystonia-parkinsonism with iron on brain imaging and we suggest classifying as NBIA type 3.

Original languageEnglish
Pages (from-to)979-984
Number of pages6
JournalMovement Disorders
Volume25
Issue number8
DOIs
StatePublished - 15 Jun 2010
Externally publishedYes

Keywords

  • ATP13A2
  • Brain iron
  • Dystonia parkinsonism
  • Iron deposition
  • Kufor Rakeb
  • NBIA
  • Neurodegeneration with brain iron accumulation
  • PARK9
  • Parkinson genetics

Fingerprint

Dive into the research topics of 'ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation'. Together they form a unique fingerprint.

Cite this